FDA Approves Addition to CIALIS® (tadalafil) Product Label
Eli Lilly and Company announced the U.S. FDA approved a product label addition for CIALIS...
The Netherlands-based company Prosena has begun the submission process for drisapersen, its treatment for...
The news is a remarkable turnaround for the drug, which had looked doomed to failure...
Oramed recruits patients to study orally ingestible insulin capsule
Oramed Pharmaceuticals has started recruiting patients for a new clinical trial of ORMD-0801, an orally...
DiaMedica completes enrollment in DM199 single ascending dose diabetes study
Clinical stage biopharmaceutical company DiaMedica has completed enrollment of type 2 diabetic patients in the...
Eli Lilly reports positive data from Phase III study of Cialis
Eli Lilly and Company has reported positive data from the Phase III study of...
Diffusion completes enrolling brain cancer patients in TSC Phase II trial
Diffusion Pharmaceuticals has completed enrolling 56 patients with newly diagnosed primary brain cancer (glioblastoma...
Boston Therapeutics presents PAZ320 drug positive Phase ll results
Boston Therapeutics has presented positive results of its PAZ320 drug, designed for reducing post-meal...
Avaxia treats first patient in ulcerative colitis drug study
Avaxia Biologics has treated the first patient in a Phase1b clinical study using AVX...
CSL Behring begins pediatric Phase III hemophilia B study of rIX-FP
CSL Behring has commenced the patient enrollment in pivotal pediatric Phase III hemophilia B...
GlycoMimetics completes enrollment in Phase 2 study of GMI-1070
Clinical-stage biotechnology company GlycoMimetics has completed patient enrollment for the Phase 2 sickle cell...